- Home
- ROIV vs WSC Comparison
ROIV vs WSC Comparison
Compare ROIV & WSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- WSC
- Stock Information
- Founded
- ROIV 2014
- WSC 1944
- Country
- ROIV United Kingdom
- WSC United States
- Employees
- ROIV N/A
- WSC N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- WSC Misc Corporate Leasing Services
- Sector
- ROIV Health Care
- WSC Industrials
- Exchange
- ROIV Nasdaq
- WSC Nasdaq
- Market Cap
- ROIV 7.8B
- WSC 4.8B
- IPO Year
- ROIV N/A
- WSC N/A
- Fundamental
- Price
- ROIV $10.99
- WSC $28.90
- Analyst Decision
- ROIV Buy
- WSC Buy
- Analyst Count
- ROIV 4
- WSC 9
- Target Price
- ROIV $17.50
- WSC $40.63
- AVG Volume (30 Days)
- ROIV 7.2M
- WSC 1.9M
- Earning Date
- ROIV 08-07-2025
- WSC 07-31-2025
- Dividend Yield
- ROIV N/A
- WSC 0.97%
- EPS Growth
- ROIV N/A
- WSC N/A
- EPS
- ROIV N/A
- WSC 0.08
- Revenue
- ROIV $29,053,000.00
- WSC $2,368,088,000.00
- Revenue This Year
- ROIV $2.64
- WSC N/A
- Revenue Next Year
- ROIV $378.09
- WSC $5.14
- P/E Ratio
- ROIV N/A
- WSC $352.72
- Revenue Growth
- ROIV N/A
- WSC N/A
- 52 Week Low
- ROIV $8.73
- WSC $21.91
- 52 Week High
- ROIV $13.06
- WSC $43.80
- Technical
- Relative Strength Index (RSI)
- ROIV 44.89
- WSC 58.84
- Support Level
- ROIV $10.83
- WSC $27.12
- Resistance Level
- ROIV $11.82
- WSC $28.10
- Average True Range (ATR)
- ROIV 0.32
- WSC 0.97
- MACD
- ROIV -0.07
- WSC 0.20
- Stochastic Oscillator
- ROIV 16.75
- WSC 89.61
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About WSC WillScot Mobile Mini Holdings Corp.
WillScot Holdings Corp designs, delivers, and services onsite, on-demand space solutions for clients. The company offers turnkey solutions in construction, education, manufacturing, retail, healthcare, and entertainment sectors. The products of the company includes modular office complexes, mobile offices, portable storage containers, and others.